Significant racial and ethnic differences have been identified in late-life depression severity, symptom burden, and depression care.
The results provide insights into the underlying causes of relapse and can be used to gain further understanding of the long-term effect of pharmacotherapy for sustained opioid use disorder recovery.
Researchers examined the association between mental health conditions and the risk for chronic opioid therapy in patients with rheumatoid arthritis.
Researchers sought to better understand the clinical practice patterns of ob-gyn physicians regarding their screening practices and management of depression during menopause.
Early-life stress caused by adverse childhood experiences (ACEs) has been linked to alterations in HPA axis activity that persist into adulthood, which may play a role in mental health disorders, including depression.
Depression, anxiety, and reduced quality of life are seen more frequently in patients with atopic eczema—and these associations imply that it may be more than just a skin disease.
Kratom is used for symptoms of pain, anxiety, depression, and opioid withdrawal, and serious adverse events are uncommon.
Women with insomnia were more likely to report prior or current depression than women without insomnia in the study.
Although emerging adults reported a higher prevalence of intravenous drug use and more severe employment, legal, and psychiatric problems at intake, they achieved dramatic improvements in response to interim buprenorphine treatment.
Depression and anxiety are common in patients with rheumatoid arthritis.